Point72 Hong Kong Ltd - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2021$49,000
+145.0%
5,315
+231.4%
0.00%
-60.0%
Q2 2019$20,000
+900.0%
1,604
+4235.1%
0.01%
+400.0%
Q2 2018$2,000
-33.3%
37
-24.5%
0.00%
-50.0%
Q1 2018$3,000
-25.0%
49
+22.5%
0.00%
-33.3%
Q4 2017$4,0000.0%40
-66.4%
0.00%
-25.0%
Q4 2016$4,000
-84.6%
119
-86.8%
0.00%
-92.2%
Q1 2016$26,0009000.05%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders